Aug 17 (Reuters) – US drug developer Novavax Inc said on Monday that it is launching a mid-term study of its experimental COVID-19 vaccine in South Africa as the country experiences an increase in coronavirus cases. The Phase 2b trial of NVX-CoV2373 will be performed on approximately 2,665 healthy adults …
Read More »
WASHINGTON (Reuters) – A former senior Trump administration official said Monday that the United States is “less secure” under the Republican president because he endorsed Democratic challenger Joe Biden for the November election. PHOTO PHOTO: US President Donald Trump arrives to address a briefing on the coronavirus (COVID-19) disease pandemic …
Read More »
LONDON – In a U-turn after days of criticism, the British government on Monday scrapped an exam grading policy that was introduced to deprive thousands of graduates of secondary school – especially minor disadvantages – from places at universities. Roger Taylor, chairman of UK Exam regulator Ofqual, said the use …
Read More »
(Reuters) – More than a dozen states as early as this week are expected to prosecute the Trump administration over cuts to the U.S. Postal Service, which they say post-in-ballots in the election of November may be delayed, Maryland Attorney General Brian Frosh said on Monday. Mailboxes of the US …
Read More »
Text size Sanofi is limiting its focus on drug development, stopping its diabetes and cardiovascular research. Joel Saget / AFP via Getty Images French pharmaceutical giant Sanofi is digging into the cash it raised earlier this year with the sale of its $ 11.7 billion stake in Regeneron Pharmaceuticals, the …
Read More »